Register
  • Community
    • Physicians
    • Editors
    • Experts
    • Code of conduct
    • Blog
    • Terms of Use
    • Privacy Policy
    • Sitemap
  • Company
    • About
    • Publications
    • Press
    • Careers
  • Programs
    • Journal Club
    • Targeted Topic
    • Clinical Trial
    • Tumor Board
  • Contact Us
  • Sign in

Neurology

Thoracic Malignancies   

Questions discussed in this category


Are there any risk factors for IO induced rhabdomyolysis and how do you approach and manage it?
2 Answers available

What are your recommendations for a patient with metastatic non-mutated lung adenocarcinoma who previously had headaches responsive to prednisone but with negative temporal artery biopsy for GCA?
For medical oncologists, would you offer a PD-1/L1 inhibitor? For other subspecialties, how would you counsel the oncologist regarding the risk of usi...
1 Answer available
1436811863


Papers discussed in this category


Journal of immunotherapy (Hagerstown, Md. : 1997), 2018-05
PD-1 Inhibitor-associated Myopathies: Emerging Immune-mediated Myopathies.

Neurology, 2019 Mar 08
Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: Systematic review.

Front Immunol, 2022 Aug 22
Neuromuscular junction dysfunctions due to immune checkpoint inhibitors therapy: An analysis of FAERS data in the past 15 years.

Related Topics in Neurology

  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Cancers
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Non-malignant Disease
  • Pediatric Oncology

Copyright © 2023 theMednet
All Rights Reserved.